BALCX
Price
$35.42
Change
-$0.04 (-0.11%)
Updated
Jun 5 closing price
Net Assets
243.73B
FSNIX
Price
$16.20
Change
-$0.01 (-0.06%)
Updated
Jun 5 closing price
Net Assets
4.3B
Interact to see
Advertisement

BALCX vs FSNIX

Header iconBALCX vs FSNIX Comparison
Open Charts BALCX vs FSNIXBanner chart's image
American Funds American Balanced C
Price$35.42
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets243.73B
Fidelity Advisor Asset Manager 60% I
Price$16.20
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets4.3B
BALCX vs FSNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. FSNIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and FSNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 244B vs. FSNIX (4.3B). FSNIX pays higher dividends than BALCX: FSNIX (2.04) vs BALCX (1.24). BALCX was incepted earlier than FSNIX: BALCX (24 years) vs FSNIX (18 years). BALCX (1.31) is less costly to investors than FSNIX (0.69). BALCX is a more actively managed with annual turnover of: 44.00 vs. FSNIX (17.00). FSNIX has a lower initial minimum investment than BALCX: FSNIX (0) vs BALCX (250). FSNIX annual gain was more profitable for investors over the last year : 7.26 vs. BALCX (6.16). FSNIX return over 5 years is better than : 34.97 vs. BALCX (30.52).
BALCXFSNIXBALCX / FSNIX
Total Expense Ratio1.310.69190%
Annual Report Gross Expense Ratio1.310.69190%
Fund Existence24 years18 years-
Gain YTD4.2804.64892%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets244B4.3B5,677%
Annual Yield % from dividends1.242.0461%
Returns for 1 year6.167.2685%
Returns for 3 years20.8620.80100%
Returns for 5 years30.5234.9787%
Returns for 10 years52.6758.4290%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRK20.680.28
+1.37%
A-Mark Precious Metals
ENTA7.200.09
+1.27%
Enanta Pharmaceuticals
XP19.780.20
+1.02%
XP
GTBP2.700.01
+0.42%
GT Biopharma
IIPR54.78-0.56
-1.01%
Innovative Industrial Properties